SELLAS Life Sciences Group, Inc. SLS Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by SELLAS Life Sciences Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about SELLAS Life Sciences Group, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is SELLAS Life Sciences Group, Inc.'s accrued expenses?
- SELLAS Life Sciences Group, Inc. (SLS) reported accrued expenses of $2.26M in Q1 2026.
- How has SELLAS Life Sciences Group, Inc.'s accrued expenses changed year-over-year?
- SELLAS Life Sciences Group, Inc.'s accrued expenses decreased by 12.1% year-over-year, from $2.57M to $2.26M.
- What is the long-term trend for SELLAS Life Sciences Group, Inc.'s accrued expenses?
- Over 5 years (2020 to 2025), SELLAS Life Sciences Group, Inc.'s accrued expenses has grown at a 13.0% compound annual growth rate (CAGR), from $1.91M to $3.53M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.